Literature DB >> 11500395

Potent stimulation of the innate immune system by a Leishmania brasiliensis recombinant protein.

M M Borges1, A Campos-Neto, P Sleath, K H Grabstein, P J Morrissey, Y A Skeiky, S G Reed.   

Abstract

The interaction of the innate immune system with the microbial world involves primarily two sets of molecules generally known as microbial pattern recognition receptors and microbial pattern recognition molecules, respectively. Examples of the former are the Toll receptors present particularly in macrophages and dendritic cells. Conversely, the microbial pattern recognition molecules are conserved protist homopolymers, such as bacterial lipopolysaccharides, lipoteichoic acids, peptidoglycans, glucans, mannans, unmethylated bacterial DNA, and double-strand viral RNA. However, for protists that lack most of these molecules, such as protozoans, the innate immune system must have evolved receptors that recognize other groups of microbial molecules. Here we present evidence that a highly purified protein encoded by a Leishmania brasiliensis gene may be one such molecule. This recombinant leishmanial molecule, a homologue of eukaryotic ribosomal elongation and initiation factor 4a (LeIF), strongly stimulates spleen cells from severe combined immunodeficient (SCID) mice to produce interleukin-12 (IL-12), IL-18, and high levels of gamma interferon. In addition, LeIF potentiates the cytotoxic activity of the NK cells of these animals. Because LeIF is a conserved molecule and because SCID mice lack T and B lymphocytes but have a normal innate immune system (normal reticuloendothelial system and NK cells), these results suggest that proteins may also be included as microbial pattern recognition molecules. The nature of the receptor involved in this innate recognition is unknown. However, it is possible to exclude the Toll receptor Tlr4 as a putative LeIF receptor because the gene encoding this receptor is defective in C3H/HeJ mice, the mouse strain used in the present studies.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11500395      PMCID: PMC98635          DOI: 10.1128/IAI.69.9.5270-5277.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

Review 1.  Innate immunity.

Authors:  R Medzhitov; C Janeway
Journal:  N Engl J Med       Date:  2000-08-03       Impact factor: 91.245

Review 2.  T-cell antigen receptor genes and T-cell recognition.

Authors:  M M Davis; P J Bjorkman
Journal:  Nature       Date:  1988-08-04       Impact factor: 49.962

3.  Natural killer cells and their precursors in mice with severe combined immunodeficiency.

Authors:  V Kumar; J Hackett; M M Tutt; B A Garni-Wagner; W A Kuziel; P W Tucker; M Bennett
Journal:  Curr Top Microbiol Immunol       Date:  1989       Impact factor: 4.291

4.  Highly purified glycosylphosphatidylinositols from Trypanosoma cruzi are potent proinflammatory agents.

Authors:  I C Almeida; M M Camargo; D O Procópio; L S Silva; A Mehlert; L R Travassos; R T Gazzinelli; M A Ferguson
Journal:  EMBO J       Date:  2000-04-03       Impact factor: 11.598

5.  Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18.

Authors:  B R Lauwerys; J C Renauld; F A Houssiau
Journal:  Cytokine       Date:  1999-11       Impact factor: 3.861

6.  DNA from protozoan parasites Babesia bovis, Trypanosoma cruzi, and T. brucei is mitogenic for B lymphocytes and stimulates macrophage expression of interleukin-12, tumor necrosis factor alpha, and nitric oxide.

Authors:  L K Shoda; K A Kegerreis; C E Suarez; I Roditi; R S Corral; G M Bertot; J Norimine; W C Brown
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.

Authors:  B R Lauwerys; N Garot; J C Renauld; F A Houssiau
Journal:  J Immunol       Date:  2000-08-15       Impact factor: 5.422

8.  Functional status of cells from lymphoid and myeloid tissues in mice with severe combined immunodeficiency disease.

Authors:  K Dorshkind; G M Keller; R A Phillips; R G Miller; G C Bosma; M O'Toole; M J Bosma
Journal:  J Immunol       Date:  1984-04       Impact factor: 5.422

9.  Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4)

Authors:  S T Qureshi; L Larivière; G Leveque; S Clermont; K J Moore; P Gros; D Malo
Journal:  J Exp Med       Date:  1999-02-15       Impact factor: 14.307

10.  An expanded population of natural killer cells in mice with severe combined immunodeficiency (SCID) lack rearrangement and expression of T cell receptor genes.

Authors:  R J Lauzon; K A Siminovitch; G M Fulop; R A Phillips; J C Roder
Journal:  J Exp Med       Date:  1986-11-01       Impact factor: 14.307

View more
  7 in total

1.  FimH can directly activate human and murine natural killer cells via TLR4.

Authors:  M Firoz Mian; Nicole M Lauzon; David W Andrews; Brian D Lichty; Ali A Ashkar
Journal:  Mol Ther       Date:  2010-05-04       Impact factor: 11.454

2.  Fungal antigens expressed during invasive aspergillosis.

Authors:  Nicole Denikus; Foteini Orfaniotou; Gerald Wulf; Paul F Lehmann; Michel Monod; Utz Reichard
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Cytokines, signaling pathways, and effector molecules required for the control of Leishmania (Viannia) braziliensis in mice.

Authors:  F Janaina Soares Rocha; Ulrike Schleicher; Jochen Mattner; Gottfried Alber; Christian Bogdan
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

4.  Leish-111f, a recombinant polyprotein vaccine that protects against visceral Leishmaniasis by elicitation of CD4+ T cells.

Authors:  Rhea N Coler; Yasuyuki Goto; Lisa Bogatzki; Vanitha Raman; Steven G Reed
Journal:  Infect Immun       Date:  2007-07-02       Impact factor: 3.441

Review 5.  Natural killer cells in experimental and human leishmaniasis.

Authors:  Christian Bogdan
Journal:  Front Cell Infect Microbiol       Date:  2012-05-29       Impact factor: 5.293

6.  Ultradeformable Archaeosomes for Needle Free Nanovaccination with Leishmania braziliensis Antigens.

Authors:  Leticia H Higa; Laura Arnal; Mónica Vermeulen; Ana Paula Perez; Priscila Schilrreff; Cecilia Mundiña-Weilenmann; Osvaldo Yantorno; María Elena Vela; María José Morilla; Eder Lilia Romero
Journal:  PLoS One       Date:  2016-03-02       Impact factor: 3.240

7.  Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime) and the recombinant Leish-110f + MPL-SE vaccine to treat canine visceral leishmaniasis.

Authors:  Jorge Miret; Evaldo Nascimento; Weverton Sampaio; João Carlos França; Ricardo Toshio Fujiwara; André Vale; Edelberto Santos Dias; Edvá Vieira; Roberto Teodoro da Costa; Wilson Mayrink; Antonio Campos Neto; Steven Reed
Journal:  Vaccine       Date:  2008-02-04       Impact factor: 3.641

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.